0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About RRP
English
DONATE
Folder: For Patients
Back
Folder: For Researchers
Back
Folder: For Clinicians
Back
Folder: Take Action
Back
Folder: About RRP
Back
English
Back
DONATE
  • Medical Education Webinars,
  • Patient Videos & Webinars,
• 8/7/24

2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Hereditary Hematologic Malignancy Assessment: Making it Mainstream

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?

You Might Also Like

Related Embedded Video Item Thumbnail Dr Blum Health Immune System 2020 RUNX1 Conference
Related Embedded Video Item Thumbnail Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (July 2024)
Related Embedded Video Item Thumbnail Module 2: The Therapeutic Potential of Increasing RUNX1 Activity Using a Drug
Related Embedded Video Item Thumbnail The RUNX1 Research Program - 5 Years of Success
Related Embedded Video Item Thumbnail Transcription Factor Associations Fine-Tune Expression of the RUNX1 Gene Network to Confer Regulatory Logic to Hematopoietic Gene Expression Programs
Name *
Thank you!

Sign up to receive the latest RRP news and updates.

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

DONATE
SHOP